Table 3. PFT findings of PM/DM associated ILD patients according to the relapse status.
Item | Relapse group (n=36) | Non-relapse group (n=38) | P value |
---|---|---|---|
FVC (L) | 2.01 (1.19–3.48) | 1.73 (0.95–2.78) | 0.17 |
%FVC (%) | 76.1 (60.7–100.6) | 70.6 (44.8–113.2) | 0.41 |
TLC (L) | 3.89 (3.15–5.69) | 3.22 (2.27–4.88) | 0.10 |
%TLC (%) | 90.9 (81–106.8) | 82.2 (49.3–126.8) | 0.36 |
%DLco (%) | 94.8 (48.8–192.3) | 60.7 (33.2–101.3) | 0.11 |
Data are expressed as median (minimum to maximum). PM, polymyositis; DM, dermatomyositis; PFT, pulmonary function test; ILD, interstitial lung disease; FVC, forced vital capacity; %FVC, percent predicted forced vital capacity; TLC, total lung capacity; %TLC, percent predicted total lung capacity; %DLco, percent predicted diffusing capacity for carbon dioxide.